Skip to main content

Advertisement

Log in

Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Autoimmune hepatitis (AIH) is characterized by progressive inflammation and necrosis of hepatocytes and eventually leads to a variety of phenotypes, including acute liver dysfunction, chronic progressive liver disease, and fulminant hepatic failure. Although the precise mechanisms of AIH are unknown, environmental factors may trigger disease onset in genetically predisposed individuals. Patients with the recently established entity of AIH with acute presentation often display atypical clinical features that mimic those of acute hepatitis forms even though AIH is categorized as a chronic liver disease. The aim of this study was to identify the precise clinical features of AIH with acute presentation.

Methods

Eighty-six AIH patients with acute presentation were retrospectively enrolled from facilities across Japan and analyzed for clinical features, histopathological findings, and disease outcomes.

Results

Seventy-five patients were female and 11 were male. Patient age ranged from adolescent to over 80 years old, with a median age of 55 years. Median alanine transaminase (ALT) was 776 U/L and median immunoglobulin G (IgG) was 1671 mg/dL. There were no significant differences between genders in terms of ALT (P = 0.27) or IgG (P = 0.51). The number of patients without and with histopathological fibrosis was 29 and 57, respectively. The patients with fibrosis were significantly older than those without (P = 0.015), but no other differences in clinical or histopathological findings were observed. Moreover, antinuclear antibody (ANA)-positive (defined as × 40, N = 63) and -negative (N = 23) patients showed no significant differences in clinical or histopathological findings or disease outcomes. Twenty-five patients experienced disease relapse and two patients died during the study period. ALP ≥ 500 U/L [odds ratio (OR) 3.20; 95% confidence interval (CI) 1.12–9.10; P < 0.030] and GGT ≥ 200 U/L (OR 2.98; 95% CI 1.01–8.77; P = 0.047) were identified as independent risk factors of disease relapse.

Conclusions

AIH with acute presentation is a newly recognized disease entity for which diagnostic hallmarks, such as ALT, fibrosis, and ANA, are needed. Further investigation is also required on the mechanisms of this disorder. Clinicians should be mindful of disease relapse during patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354(1):54–66.

    Article  PubMed  CAS  Google Scholar 

  2. Mehendiratta V, Mitroo P, Bombonati A, et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol. 2009;7(1):98–103.

    Article  PubMed  Google Scholar 

  3. Seki T, Kiyosawa K, Ota M, et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology. 1993;18(1):73–8.

    Article  PubMed  CAS  Google Scholar 

  4. Yoshizawa K, Ota M, Katsuyama Y, et al. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J Hepatol. 2005;42(4):578–84.

    Article  PubMed  CAS  Google Scholar 

  5. Yoshizawa K, Umemura T, Ota M. Genetic background of autoimmune hepatitis in Japan. J Gastroenterol. 2011;46(Suppl 1):42–7.

    Article  PubMed  CAS  Google Scholar 

  6. Umemura T, Ota M, Yoshizawa K, et al. Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese. Hepatol Res. 2008;38(7):689–95.

    Article  PubMed  CAS  Google Scholar 

  7. Yokosawa S, Yoshizawa K, Ota M, et al. A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1. Hepatology. 2007;45(2):384–90.

    Article  PubMed  CAS  Google Scholar 

  8. Umemura T, Joshita S, Hamano H, et al. Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients. J Hum Genet. 2017;62(11):963–7.

    Article  PubMed  CAS  Google Scholar 

  9. de Boer YS, van Gerven NM, Zwiers A, et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology. 2014;147(2):443–52.

    Article  PubMed  CAS  Google Scholar 

  10. van Gerven NM, Verwer BJ, Witte BI, et al. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014;49(10):1245–54.

    Article  PubMed  CAS  Google Scholar 

  11. Gronbaek L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60(3):612–7.

    Article  PubMed  Google Scholar 

  12. Yoshizawa K, Joshita S, Matsumoto A, et al. Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan. Hepatol Res. 2016;46(9):878–83.

    Article  PubMed  Google Scholar 

  13. Takahashi H, Zeniya M. Acute presentation of autoimmune hepatitis: does it exist? A published work review. Hepatol Res. 2011;41(6):498–504.

    Article  PubMed  Google Scholar 

  14. Ohira H, Abe K, Takahashi A, et al. Autoimmune hepatitis: recent advances in the pathogenesis and new diagnostic guidelines in Japan. Intern Med. 2015;54(11):1323–8.

    Article  PubMed  CAS  Google Scholar 

  15. Lefkowitch JH, Apfelbaum TF, Weinberg L, et al. Acute liver biopsy lesions in early autoimmune (“lupoid”) chronic active hepatitis. Liver. 1984;4(6):379–86.

    Article  PubMed  CAS  Google Scholar 

  16. Takahashi A, Arinaga-Hino T, Ohira H, et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol. 2017;52(5):631–40.

    Article  PubMed  CAS  Google Scholar 

  17. EASL Clinical Practice Guidelines. Autoimmune hepatitis. J Hepatol. 2015;63(4):971–1004.

    Article  Google Scholar 

  18. Onji M, Zeniya M, Yamamoto K, et al. Autoimmune hepatitis: diagnosis and treatment guide in Japan, 2013. Hepatol Res. 2014;44(4):368–70.

    Article  PubMed  Google Scholar 

  19. Nguyen Canh H, Harada K, Ouchi H, et al. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol. 2017;70(11):961–9.

    Article  PubMed  Google Scholar 

  20. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929–38.

    Article  PubMed  CAS  Google Scholar 

  21. Okano N, Yamamoto K, Sakaguchi K, et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol Res. 2003;25(3):263–70.

    Article  PubMed  Google Scholar 

  22. Miyake Y, Iwasaki Y, Kobashi H, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis. 2010;42(1):51–4.

    Article  PubMed  CAS  Google Scholar 

  23. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169–76.

    Article  PubMed  Google Scholar 

  24. Tiniakos DG, Brain JG, Bury YA. Role of histopathology in autoimmune hepatitis. Dig Dis. 2015;33(Suppl 2):53–64.

    Article  PubMed  Google Scholar 

  25. Muratori P, Granito A, Quarneti C, et al. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol. 2009;50(6):1210–8.

    Article  PubMed  Google Scholar 

  26. Yoshizawa K, Matsumoto A, Ichijo T, et al. Long-term outcome of Japanese patients with type 1 autoimmune hepatitis. Hepatology. 2012;56(2):668–76.

    Article  PubMed  Google Scholar 

  27. Sanchez-Urdazpal L, Czaja AJ, van Hoek B, et al. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology. 1992;15(2):215–21.

    Article  PubMed  CAS  Google Scholar 

  28. Czaja AJ, Menon KV, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology. 2002;35(4):890–7.

    Article  PubMed  CAS  Google Scholar 

  29. Alla V, Abraham J, Siddiqui J, et al. Autoimmune hepatitis triggered by statins. J Clin Gastroenterol. 2006;40(8):757–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Trevor Ralph for his English editorial assistance.

Funding

This study was conducted and supported by Health Labor Science Research Grants from Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Kaname Yoshizawa.

Ethics declarations

Conflict of interest

The authors declare that they have nothing to disclose regarding funding from industries or other conflicts of interest with respect to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joshita, S., Yoshizawa, K., Umemura, T. et al. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey. J Gastroenterol 53, 1079–1088 (2018). https://doi.org/10.1007/s00535-018-1444-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-018-1444-4

Keywords

Navigation